Evidence map›Paper›PMID 27697903›Full record

ArticleDevelopment (Cambridge, England)2016

Reversible optogenetic control of kinase activity during differentiation and embryonic development.

Vishnu V Krishnamurthy, John S Khamo, Wenyan Mei, Aurora J Turgeon, Humza M Ashraf, Payel Mondal, Dil B Patel, Noah Risner, Ellen E Cho, Jing Yang and 1 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Optogenetic Signaling Activation in Zebrafish Embryos.Journal of visualized experiments : JoVE · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vishnu V KrishnamurthyDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-9905-5965
John S KhamoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-7179-0589
Wenyan MeiDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Aurora J TurgeonDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Humza M AshrafDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-7042-312X
Payel MondalDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Dil B PatelDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0003-4567-8774
Noah RisnerDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Ellen E ChoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-7953-2736
Jing YangDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA yangj@illinois.edu kaizkaiz@illinois.edu.ORCID 0000-0002-4983-1660
Kai ZhangDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA yangj@illinois.edu kaizkaiz@illinois.edu.ORCID 0000-0002-6687-4558

Funding

Maternal control of germline developmentR35GM131810 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Jing Yang · 2019 to 2026
$3.2M
Dnd1 and repression of transcription in primordial germ cellsR01GM111816 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI YANG, JING · 2015 to 2018
$1.2M
NIGMS NIH HHS R01 GM111816NIGMS NIH HHS R35 GM131810
6 · The paper itself

Abstract

A limited number of signaling pathways are repeatedly used to regulate a wide variety of processes during development and differentiation. The lack of tools to manipulate signaling pathways dynamically in space and time has been a major technical challenge for biologists. Optogenetic techniques, which utilize light to control protein functions in a reversible fashion, hold promise for modulating intracellular signaling networks with high spatial and temporal resolution. Applications of optogenetics in multicellular organisms, however, have not been widely reported. Here, we create an optimized bicistronic optogenetic system using Arabidopsis thaliana cryptochrome 2 (CRY2) protein and the N-terminal domain of cryptochrome-interacting basic-helix-loop-helix (CIBN). In a proof-of-principle study, we develop an optogenetic Raf kinase that allows reversible light-controlled activation of the Raf/MEK/ERK signaling cascade. In PC12 cells, this system significantly improves light-induced cell differentiation compared with co-transfection. When applied to Xenopus embryos, this system enables blue light-dependent reversible Raf activation at any desired developmental stage in specific cell lineages. Our system offers a powerful optogenetic tool suitable for manipulation of signaling pathways with high spatial and temporal resolution in a wide range of experimental settings.

Indexed as

AnimalsArabidopsisArabidopsis ProteinsCell DifferentiationCryptochromesEmbryonic DevelopmentLightMAP Kinase Signaling SystemOptogeneticsPC12 CellsPhosphorylationPhosphotransferasesraf KinasesRatsSignal TransductionTransgenesArabidopsis ProteinsCRY2 protein, ArabidopsisCryptochromesPhosphotransferasesraf KinasesBicistronic gene expressionCryptochromeDifferentiationLight-controlled protein-protein interactionOptogeneticsXenopus

Identifiers

PMID27697903
PMCPMC5117147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.